Yet Another Value Podcast

Lionel Hutz on Liquidia's patent battle $LQDA

12.19.2022 - By Andrew WalkerPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR).

Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia

Chapters 

0:00 Intro 

2:50 LQDA overview 

8:05 Diving into the patent background 

16:10 Breaking down the conflicting rulings on the '793 patent 

19:55 Why the PTAB ruling is the most important for '793 

21:55 What's so unique about the judge's ruling on '793 

28:30 Why PTAB ruled the '793 patent invalid 

37:40 LQDA's primary argument for invalidating '793 

43:30 Discussing the expert reports around the '793 patent 

53:30 Timeline to monetization and why delaying LQDA is so important for UTHR 

59:00 LQDA's upside if they win 

1:13:00 LQDA's cash runway

More episodes from Yet Another Value Podcast